The author of the new article writes:
In a thoughtful and precise paper, the International Myeloma Working Group (IMWG) last fall expanded the definition of multiple myeloma to include 3 groups of asymptomatic individuals as patients with the disease, because of data that each group is highly likely to develop organ or bone damage within 2 years ...
I initially worried that these new disease definitions might lead to frequent overtreatment, especially when decisions to treat the patient as overt multiple myeloma are left to busy physicians who mechanically apply guidelines. On reflection, these considerations are outweighed by the benefits to thoughtful and conscientious physicians and their patients of expanding the disease definitions to include these ominous situations.
You can read the full article here:
S Vogl, "Diagnostic Expansion in multiple myeloma: Elegant, Thoughtful, but Risky," Clinical Oncology News, May 1, 2015 (full text of article)
What do you see as the main points in the article? Was there anything that surprised you, or which you found particularly interesting?
